Onkologie. 2010:4(6):353-356
Breast screening results in an ever-increasing proportion of ductal carcinoma in situ (DCIS) in the spectrum of newly detected breast cancers.
It is a heterogeneous group of tumours. DCIS without microinvasion does not extend beyond the basal membrane and metastasize.
Although it accounts for up to 20 % of breast cancers in countries with advanced screening programmes, there is a lot of controversy over
its classification and treatment. Breast conservative procedures that are an alternative to mastectomy in early breast cancer have been
included in the treatment of DCIS as well. There is still no consensus on the width of the resection margin. Sentinel lymph node biopsy
(SLNB) is indicated in mastectomy. The indication of SLNB in conservative procedures is controversial. SLNB is performed in cases when
there is a risk of DCIS with foci of microinvasion and/or a risk of invasive carcinoma.
Published: January 1, 2011 Show citation